MITA News

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA) today said that the Centers for Medicare & Medicaid Services’ (CMS) draft decision proposing Coverage with Evidence Development (CED) for the use of beta amyloid positron emission tomography (PET) imaging falls short of providing Medicare beneficiaries with suspected dementia or Alzheimer’s Disease (AD) appropriate access to this ground-breaking diagnostic technology.

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA) today applauded a new analysis of the 2010 National Lung Screening Trial (NLST) indicating that low-dose computed tomography (LDCT) for patients at high risk for lung cancer is a cost effective diagnostic tool. The study was presented earlier this week at a Joint Meeting of the National Institutes of Health Board of Scientific Advisors and National Cancer Advisory Board.

  • MITA Statement

    Today, the leading global medical technology industry associations AdvaMed, COCIR, MITA and MedTech Europe (the alliance of European medical technology industry associations EDMA and Eucomed) applaud the announcement to launch trade negotiations between the United States and European Union.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today commended Energy and Natural Resources Committee Chairman Senator Ron Wyden (D-OR) and Ranking Member Senator Lisa Murkowski (R-AK) for their bipartisan leadership in achieving unanimous Committee approval for the Helium Stewardship Act of 2013 (S. 783). In a letter to Senate leadership, MITA urged Senate Majority Leader Harry Reid (D-NV) and Senate Republican Leader Mitch McConnell (R-KY) to act quickly in approving the bipartisan legislation, which passed the Committee by voice vote on Tuesday.

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA) today highlighted a new study published in the June 10 issue of Value in Health that found consumers place considerable value on diagnostic information. These findings are corroborated by a recent Harris Interactive survey confirming that the majority of Americans would want to know if they have a serious illness or injury.

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) today commended the Centers for Medicare & Medicaid Services (CMS) for ending the Coverage with Evidence Development (CED) requirement for fluorodeoxyglucose positron emission tomography (FDG-PET) for oncology in its final decision memo on PET for solid tumors. The decision removes the requirement for prospective data Read More

  • MITA Statement

    Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) and the American Association of Physicists in Medicine (AAPM) today said that a study on the use of pediatric computed tomography (CT) published in the June issue of JAMA Pediatrics underscores the importance of radiation dose safety standards, initiatives and manufacturer innovations to help ensure the Read More

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA), together with the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR) and the Global Diagnostic Imaging, Healthcare IT, and Radiation Therapy Trade Association (DITTA), today commended progress made at the first Global Summit on Radiological Quality and Safety (GSRQS) Summit. During the Summit, participants underscored the importance of making dose optimization and appropriate use criteria global priorities.

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA) and the Lung Cancer Alliance (LCA) today hailed a new analysis of the 2010 National Lung Screening Trial (NLST) reconfirming that low-dose computed tomography (CT) scans can diagnose lung cancer at early stage and reduce deaths.

  • MITA Statement

    The Medical Imaging & Technology Alliance (MITA) announced today that the Computed Tomography (CT) Nomenclature Working Group, led by the American Association of Physicists in Medicine (AAPM), has received the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) Director’s Special Citation Award for developing CT imaging radiation safety instructional materials through a collaboration of end-users, CT manufacturers and the FDA. The award is MITA’s second recognition from the FDA.